Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Atricure Inc (ATRC)

Atricure Inc (ATRC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
AtriCure: Q4 Earnings Snapshot

AtriCure: Q4 Earnings Snapshot

ATRC : 23.20 (-0.81%)
AtriCure: Q3 Earnings Snapshot

AtriCure: Q3 Earnings Snapshot

ATRC : 23.20 (-0.81%)
AtriCure: Q2 Earnings Snapshot

AtriCure: Q2 Earnings Snapshot

ATRC : 23.20 (-0.81%)
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates

AtriCure (ATRC) delivered earnings and revenue surprises of 32.35% and 6.94%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ATRC : 23.20 (-0.81%)
ZVIA : 0.9831 (+2.41%)
AtriCure: Q1 Earnings Snapshot

AtriCure: Q1 Earnings Snapshot

ATRC : 23.20 (-0.81%)
AtriCure Reports First Quarter 2023 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today...

ATRC : 23.20 (-0.81%)
AtriCure to Participate in the 2023 Bank of America Health Care Conference and Host a Cryo Nerve Block Therapy Investor Education Webcast

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today...

ATRC : 23.20 (-0.81%)
AtriCure to Announce First Quarter 2023 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today...

ATRC : 23.20 (-0.81%)
AtriCure to Participate in the 22nd Annual Needham Virtual Healthcare Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today...

ATRC : 23.20 (-0.81%)
AtriCure (ATRC) Moves 7.5% Higher: Will This Strength Last?

AtriCure (ATRC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

ATRC : 23.20 (-0.81%)
PHG : 19.98 (unch)

Barchart Exclusives

Dividend Newcomers: Discover 3 Companies Starting To Share the Wealth
Discover the potential of newly initiated dividends—start building your wealth with tomorrow's top dividend payers today! Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar